How are maternal and fetal outcomes incorporated when measuring benefits of interventions in pregnancy? Findings from a systematic review of cost-utility analyses
Abel L. et al, (2024), Health and Quality of Life Outcomes, 22
How are maternal and fetal outcomes incorporated when measuring benefits of interventions in pregnancy? Findings from a systematic review of cost-utility analyses
Abel L. et al, (2024), Health and Quality of Life Outcomes, 22
Research inefficiencies in external validation studies of the Framingham Wilson coronary heart disease risk rule: A systematic review
Ban JW. et al, (2024), PLoS ONE, 19
Capacity-building partnerships for surgical post-graduate training in low- and middle-income countries: a scoping review of the literature with exploratory thematic synthesis
Voss M. et al, (2021), Health policy and planning, 35, 1385 - 1412
A Pregnant Pause: Rethinking Economic Evaluation in Contraception and Pregnancy
Abel L. and Quaife M., (2021), Value in Health
Preferences for Medical Consultations from Online Providers: Evidence from a Discrete Choice Experiment in the United Kingdom
Buchanan J. et al, (2021), Applied Health Economics and Health Policy
A price tag on clinical empathy? Factors influencing its cost-effectiveness
Howick J. et al, (2020), Journal of the Royal Society of Medicine, 113, 389 - 393
Why do hospital prescribers continue antibiotics when it is safe to stop? Results of a choice experiment survey
Roope LSJ. et al, (2020), BMC Medicine, 18
Early Economic Evaluation of Diagnostic Technologies: Experiences of the NIHR Diagnostic Evidence Co-operatives
Abel L. et al, (2019), Medical Decision Making, 39, 857 - 866
Use of Decision Modelling in Economic Evaluations of Diagnostic Tests: An Appraisal and Review of Health Technology Assessments in the UK
Yang Y. et al, (2019), PharmacoEconomics - Open, 3, 281 - 291
The challenge of antimicrobial resistance: What economics can contribute
Roope LSJ. et al, (2019), Science, 364
Is stratification testing for treatment of chronic obstructive pulmonary disease exacerbations cost-effective in primary care? an early cost-utility analysis
Abel L. et al, (2019), International Journal of Technology Assessment in Health Care, 35, 116 - 125